Piscataway, NJ, March 31, 2023–Camber Pharmaceuticals is pleased to announce the addition of Aminocaproic Acid Oral Solution, USP, to its current portfolio.
Aminocaproic Acid Oral Solution is useful in enhancing hemostasis when fibrinolysis contributes to bleeding.
Our raspberry flavored Aminocaproic Acid Oral Solution 0.25 g/mL is available in 8 Fl. Oz. bottles.
To find out more about Aminocaproic Acid Oral Solution please visit www.camberpharma.com
Camber Pharmaceuticals is a fully integrated pharmaceutical company. Its parent company, Hetero, of Hyderabad, India, is one of the world’s leading API and finished dosage manufacturers. Camber is committed to bringing the highest quality generic pharmaceuticals to consumers, improving quality of life through cost-effective medications.
# # #
If you would like more information about this topic, please contact Megan Little at [email protected]